Clinical characteristics and outcomes in patients with COVID‐19 and leprosy
Victor Santana Santos, Lucindo José Quintans‐Júnior, W. S. Barboza, Adriano Antunes de Souza Araújo, Paulo Ricardo Martins‐Filho
Abstract
The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly infectious virus that causes coronavirus disease 2019 (COVID-19), has raised important questions about the target groups at risk of illness and/or death. 1 COVID-19 mortality has been higher in men, older people, unassisted by health systems and those having non-communicable disease. 1,2 However, information is still lacking on how COVID-19 can affect people with infectious disease. Herein, we described the clinical features and outcomes in patients with COVID-19 and leprosy in an endemic area in Brazil.
Topics & Concepts
MedicineLeprosyCoronavirus disease 2019 (COVID-19)DiseasePopulationPublic healthInfectious disease (medical specialty)Environmental healthInternal medicineImmunologyPathologyLeprosy Research and TreatmentCOVID-19 Clinical Research StudiesDermatological and COVID-19 studies